Advances in the Use of Natural Compounds for Cancer Therapy: A Transition from Traditional Approaches to Modern Drug Guidance
DOI:
https://doi.org/10.54536/ajcp.v5i2.8073Keywords:
Apigenin, Breast Cancer, Curcumin, Cervical Cancer, Hepatocellular Carcinoma, Ovarian Cancer, Prostate CancerAbstract
Cancer is one of the most serious and leading causes of death worldwide. Many individuals incorporate natural and nutritious foods into their diets which can help prevent cancer and reduce other health risks. Although synthetic drugs are commonly used in cancer treatment and their effectiveness is often limited by drug resistance and adverse side effects. So, physicians and researchers are increasingly focusing on natural products to enhance efficacy of conventional cancer therapies and to minimize associated toxicities. A comprehensive literature search was conducted primarily in google scholar and was supplemented by searches in PubMed, Scopus and Science Direct using relevant keywords. We found that same natural product can inhibit multiple types of cancer and may also be used in combination with pharmaceutical drugs. Important fact is that many people are unaware of anticancer activities of natural products and their potential benefits. It is equally important to highlight limitations of conventional pharmaceutical treatments. So affordable yet valuable natural products should be recognized and further investigated for their therapeutic potential in cancer prevention and treatment. This study aims to discuss different types of cancer and their relationship with natural products as well as anticancer drugs. The main objective is to investigate activity of natural products against various cancer cell types and to compare their effectiveness with that of synthetic drugs used alone. This approach may help bridge traditional and modern treatments and contributing to advancement of cancer therapy in general.
Downloads
References
Amrutkar, M., & Gladhaug, I. P. (2017). Pancreatic cancer chemoresistance to gemcitabine. Cancers, 9(11), Article 157. https://doi.org/10.3390/cancers9110157
Al-Hazzani, A. A., & Alshatwi, A. A. (2011). Catechin hydrate inhibits proliferation and mediates apoptosis of SiHa human cervical cancer cells. Food and Chemical Toxicology, 49(12), 3281–3286. https://doi.org/10.1016/j.fct.2011.09.023
Abbaspour Babaei, M., Zaman Huri, H., Kamalidehghan, B., Yeap, S. K., & Ahmadipour, F. (2017). Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2’-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study. OncoTargets and therapy, 10, 277–294. https://doi.org/10.2147/OTT.S102894
Azuine, M. A., & Bhide, S. V. (1994). Adjuvant chemoprevention of experimental cancer: Catechin and dietary turmeric in forestomach and oral cancer models. Journal of Ethnopharmacology, 44(3), 211–217. https://doi.org/10.1016/0378-8741(94)01188-5
Bhuiyan, R. H., None, M., Akter, S., Rashid, M. H. B., None, E. & Jaman, S. (2022). Assessment of antioxidant and antineoplastic activities blumea lacera (Burn. F) leaves. International Academic Journal of Applied Bio-Medical Sciences, 3(2), 1-7. https://doi.org/10.47310/iajabms.2022.v03i02.001
Bhuiyan, M. R. H., Al Mamun, A., Sharker, B., & Jaman, M. S. (2023). Anticancer activity and therapeutic uses of catechins on breast, prostate and lung cancer: Future perspective and clinical proofs. Journal of Clinical Case Reports, Medical Images and Health Sciences, 3(3). https://doi.org/10.55920/JCRMHS.2023.03.001118
Bhuiyan, M. R. H., Maniruzzaman, M., Akter, S., Mehjabin, S., Rana, M. R. R., & Jaman, M. S. (2022). Drug promising effect for diabetic mice of carica papaya leaves. European Journal of Pharmaceutical Research, 2(3), 1–5. https://doi.org/10.24018/ejpharma.2022.2.3.47
Bhat, S. S., Prasad, S. K., Shivamallu, C., Prasad, K. S., Syed, A., Reddy, P., Cull, C. A., & Amachawadi, R. G. (2021). Genistein: A potent anti-breast cancer agent. Current Issues in Molecular Biology, 43(3), 1502–1517. https://doi.org/10.3390/cimb43030106
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008). Multi-targeted therapy of cancer by genistein. Cancer Letters, 269(2), 226–242. https://doi.org/10.1016/j.canlet.2008.03.052
Chen, D., Landis-Piwowar, K. R., Chen, M. S., & Dou, Q. P. (2007). Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Research, 9(6), R80. https://doi.org/10.1186/bcr1797
Bufu, T., Di, X., Yilin, Z., Gege, L., Xi, C., & Ling, W. (2018). Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway. Anti-cancer drugs, 29(6), 530–538. https://doi.org/10.1097/CAD.0000000000000621
Bowman, A., Gabra, H., Langdon, S. P., Lessells, A., Stewart, M., Young, A., & Smyth, J. F. (2002). CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(7), 2233–2239.
Bhattacharyya, R. S., Krishnan, A. V., Swami, S., & Feldman, D. (2006). Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Molecular cancer therapeutics, 5(6), 1539–1549. https://doi.org/10.1158/1535-7163.MCT-06-0065
Boccardo, F., Rubagotti, A., Battaglia, M., Di Tonno, P., Selvaggi, F. P., Conti, G., Comeri, G., Bertaccini, A., Martorana, G., Galassi, P., Zattoni, F., Macchiarella, A., Siragusa, A., Muscas, G., Durand, F., Potenzoni, D., Manganelli, A., Ferraris, V., & Montefiore, F. (2005). Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(4), 808–815. https://doi.org/10.1200/JCO.2005.12.013
Chang, M. (2012). Tamoxifen resistance in breast cancer. Biomolecules & Therapeutics, 20(3), 256–267. https://doi.org/10.4062/biomolther.2012.20.3.256
Chen, J., Yuan, C.-B., Yang, B., & Zhou, X. (2021). Baicalin inhibits EMT through PDK1/AKT signaling in human nonsmall cell lung cancer. Journal of Oncology, 2021, Article 4391581. https://doi.org/10.1155/2021/4391581
Chen, J.-C., Ko, J.-C., Yen, T.-C., Chen, T.-Y., Lin, Y.-C., Ma, P.-F., & Lin, Y.-W. (2019). Capsaicin enhances erlotinib-induced cytotoxicity via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells. Toxicology Research, 8(3), 459–470. https://doi.org/10.1039/C8TX00346G
Cui, H., Li, T., Wang, L., Su, Y., & Xian, C. J. (2016). Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in mice. Scientific Reports, 6, Article 19185. https://doi.org/10.1038/srep19185
Chang, H. L., Wu, Y. C., Su, J. H., Yeh, Y. T., & Yuan, S. S. (2008). Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. The Journal of pharmacology and experimental therapeutics, 325(3), 841–849. https://doi.org/10.1124/jpet.107.135442
Chen, H.-M., Chang, F.-R., Hsieh, Y.-C., Cheng, Y.-J., Hsieh, K.-C., Tsai, L.-M., Lin, A.-S., Wu, Y.-C., & Yuan, S.-S. F. (2011). A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Free Radical Biology and Medicine, 50(9), 1151–1162. https://doi.org/10.1016/j.freeradbiomed.2011.01.015
Chen, Y., Zhu, S., Chen, Z., Liu, Y., Pei, C., Huang, H., Hou, S., Ning, W., & Liang, J. (2022). Gingerenone a alleviates ferroptosis in secondary liver injury in colitis mice via activating nrf2-Gpx4 signaling pathway. Journal of agricultural and food chemistry, 70(39), 12525–12534. https://doi.org/10.1021/acs.jafc.2c05262
Cassidy, J., Twelves, C., Van Cutsem, E., Hoff, P., Bajetta, E., Boyer, M., Bugat, R., Burger, U., Garin, A., Graeven, U., McKendric, J., Maroun, J., Marshall, J., Osterwalder, B., Pérez-Manga, G., Rosso, R., Rougier, P., Schilsky, R. L., & Capecitabine Colorectal Cancer Study Group (2002). First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Annals of oncology : official journal of the European Society for Medical Oncology, 13(4), 566–575. https://doi.org/10.1093/annonc/mdf089
Chen, L., Waxman, D. J., Chen, D., & Kufe, D. W. (1996). Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Cancer research, 56(6), 1331–1340.
Dahut, M., Fousek, K., Horn, L. A., Angstadt, S., Qin, H., Hamilton, D. H., Schlom, J., & Palena, C. (2023). Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis. Journal for ImmunoTherapy of Cancer, 11(9), e007386. https://doi.org/10.1136/jitc-2023-007386
Diaz, L. A., Shiu, K.-K., Kim, T.-W., Jensen, B. V., Jensen, L. H., Punt, C. J. A., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., De La Fourchardiere, C., Rivera, F., Elez, E., Le, D. T., Yoshino, T., Zhong, W., Fogelman, D., Marinello, P., & André, T. (2022). Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. The Lancet Oncology, 23(5), 659–670. https://doi.org/10.1016/S1470-2045(22)00197-8
Guo, L., Yue, M., Ma, C., Wang, Y., Hou, J., & Li, H. (2024). Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis. Heliyon, 10(8), e29361. https://doi.org/10.1016/j.heliyon.2024.e29361
García-Maceira, P., & Mateo, J. (2009). Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: Implications for anticancer therapy. Oncogene, 28(3), 313–324. https://doi.org/10.1038/onc.2008.398
Gong, H. X., Yu, X. F., Zhang, A. L., Li, M., Wang, Y., & Chen, D. (2024). A novel supramolecule combining the pharmacological benefits of berberine and catechin for the prevention and treatment of cervical cancer. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 698, Article 134555. https://doi.org/10.1016/j.colsurfa.2024.134555
Hu, S., Xu, Y., Meng, L., Huang, L., & Sun, H. (2018). Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Experimental and Therapeutic Medicine, 16(2), 1266–1272. https://doi.org/10.3892/etm.2018.6345
Han, T. H., Park, M. K., Nakamura, H., & Ban, H. S. (2022). Capsaicin inhibits HIF-1α accumulation through suppression of mitochondrial respiration in lung cancer cells. Biomedicine & pharmacotherapy, Biomedecine & pharmacotherapie, 146, 112500. https://doi.org/10.1016/j.biopha.2021.112500
Heinemann, V. (2001). Gemcitabine: Progress in the treatment of pancreatic cancer. Oncology, 60(1), 8–18. https://doi.org/10.1159/000055290
Hirsch, B. R., & Zafar, S. Y. (2011). Capecitabine in the management of colorectal cancer. Cancer Management and Research, 3, 79–89. https://doi.org/10.2147/CMR.S11250
Heinzelmann-Schwarz, V., Knipprath, M., Mészáros, A., Stadlmann, S., Jacob, F., Schoetzau, A., Russell, K., Friedlander, M., Singer, G., & Vetter, M. (2018). Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients. Gynecologic Oncology, 148(1), 79–85. https://doi.org/10.1016/j.ygyno.2017.10.036
Isono-Taniguchi, R., Goto, M., Takimoto, Y., Ueda, T., Wakimoto, Y., Inoue, K., Hori, K., Ito, K., & Tsubamoto, H. (2022). Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study. Gynecologic oncology reports, 42, 101013. https://doi.org/10.1016/j.gore.2022.101013
Imohiosen, O. (2023). Phytochemical and biological screening of catholic vegetable (Jatropha Tanjorensis) aqueous extract in bali, taraba state, nigeria. American Journal of Chemistry and Pharmacy, 2(2), 37-40. https://doi.org/10.54536/ajcp.v2i2.1602
Jaman, M. S., & Sayeed, M. A. (2018). Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives. Breast cancer (Tokyo, Japan), 25(5), 517–528. https://doi.org/10.1007/s12282-018-0866-4
Jaman, M. S., Al Mamun, A., Sharker, B., Maniruzzaman, M., Rana, M. R. R., Hasan, M. N., & Bhuiyan, M. R. H. (2023). Curcumin, diallyl sulphide, quercetin and gallic acid uses as anticancer and therapeutic agents for breast cancer: Current strategies and future perspectives. European Journal of Medical and Health Sciences, 5(3), 32–48. https://doi.org/10.24018/ejmed.2023.5.3.1699
Jaman, M. S., Alam, M. S., Rezwan, M. S., Islam, M. R., Husna, A. U., & Sayeed, M. A. (2017). Comparison of total antioxidant activity between fresh and commercial mango juices available in Bangladesh. GSC Biological and Pharmaceutical Sciences, 1(2), 26–33. https://doi.org/10.30574/gscbps.2017.1.2.0045
Jaman S, Islam N, Maniruzzaman M, Hossain F, Bhuiyan RH, Emaul N. (2023) Preventive and therapeutic effect of ellagic acid, sulforaphane and ursolic acid on colon cancer: from cellular response to molecular mechanism of action with future perspectives. Int J Clin Med Case Rep.1-13.
Jaman, M. S., Sawgat, R., Alam, S., Islam, M. R., Husna, A. U., & Sayeed, M. A. (2017). Association of mean platelet volume and platelet distribution width with HbA1c. Journal of Endocrinology and Diabetes, 4(4), 1–6. https://doi.org/10.15226/2374-6890/4/4/00183
Jaman, M. S., Maniruzzaman, M., Rana, M. R. R., Bhuiyan, M. R. H., Akter, L., Ahmad, S., Ullah, M. N., & Saifujjaman, M. (2024). Overall summery of gulf country employees from Bangladesh, preliminary evaluation for abnormal kidney liver and virally infected individuals using low-cost tests like CBC parameters. Chemical Science International Journal, 33(4), 19–33. https://doi.org/10.9734/CSJI/2024/v33i4903
Jaman, M. S., Rahman, M. S., Swarna, R. R., Mahato, J., Miah, M. M., & Ayshasiddeka, M. (2018). Diabetes and red blood cell parameters. Annals of Clinical Endocrinology and Metabolism, 2(1), 1–9. https://doi.org/10.29328/journal.acem.1001004
Jiang, Z., Cao, Q., Dai, G., Wang, J., Liu, C., Lv, L., & Pan, J. (2019). Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling. OncoTargets and Therapy, 12, 509–518. https://doi.org/10.2147/OTT.S187817
Jiang, M., Sun, Y. and Song, K. (2023), Ginsenoside compound K suppresses tumour growth in the 22Rv1 xenograft model and inhibits androgenic responses via the transcriptional mechanism in human prostate cancer cells. FEBS J, 290: 1840-1854. https://doi.org/10.1111/febs.16676
JAMAN, M. S. (2025). A Review Potential Radioprotective Mechanism of Molecular Hydrogen via Regulation of Cellular Signaling Pathways . Radinka journal of health science, 3(2), 503–528. https://doi.org/10.56778/rjhs.v3i2.591
Kim, J., Shrestha, C., Kim, T. W., Lee, S. B., Lee, G., Jung, D., Hwang, M., Kang, S., Park, H. S., Kim, H., An, H. J., Chae, D., Shim, B. Y., & Kim, J. (2025). Autophagy inhibition enhances sensitivity of alpelisib in PI3K–mutated non-small cell lung cancer. Biomedicine & Pharmacotherapy, 192, Article 118620. https://doi.org/10.1016/j.biopha.2025.118620
Kanai, M. (2014). Therapeutic applications of curcumin for patients with pancreatic cancer. World Journal of Gastroenterology, 20(28), 9384–9391. https://doi.org/10.3748/wjg.v20.i28.9384
Kim, K., Shin, E. A., Jung, J. H., Park, J. E., Kim, D. S., Shim, B. S., & Kim, S.-H. (2019). Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of microRNA-4500 and inhibition of JAK2/STAT3 phosphorylation. International Journal of Molecular Sciences, 20(1), Article 114. https://doi.org/10.3390/ijms20010114
Kim, Y. W., Bae, S. M., Lee, J. M., Namkoong, S. E., Han, S. J., Lee, B. R., Ahn, W. S., & Kim, C. K. (2004). Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines. Cancer Research and Treatment, 36(5), 315–323. https://doi.org/10.4143/crt.2004.36.5.315
Kankia, I. H., Khalil, H. S., Langdon, S. P., Moult, P. R., Bown, J. L., & Deeni, Y. Y. (2017). NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib. Oxidative Medicine and Cellular Longevity, 2017, Article 1864578. https://doi.org/10.1155/2017/1864578
Khojaste, E., & Ahmadizadeh, C. (2022). Catechin metabolites along with curcumin inhibit proliferation and induce apoptosis in cervical cancer cells by regulating vegf expression in-vitro.. Nutrition and cancer, 74(3), 1048–1057. https://doi.org/10.1080/01635581.2021.1936082
Lv, Z. D., Liu, X. P., Zhao, W. J., Dong, Q., Li, F. N., Wang, H. B., & Kong, B. (2014). Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. International journal of clinical and experimental pathology, 7(6), 2818–2824.
Lau, J. K., Brown, K. C., Dom, A. M., Witte, T. R., Thornhill, B. A., Crabtree, C. M., Perry, H. E., Brown, J. M., Ball, J. G., Creel, R. G., Damron, C. L., Rollyson, W. D., Stevenson, C. D., Hardman, W. E., Valentovic, M. A., Carpenter, A. B., & Dasgupta, P. (2014). Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway. Apoptosis, 19(8), 1190–1201. https://doi.org/10.1007/s10495-014-1007-y
Lin, J. H., Chen, S. Y., Lu, C. C., Lin, J. A., & Yen, G. C. (2020). Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells. Phytotherapy Research, 34(8), 2053–2066. https://doi.org/10.1002/ptr.6669
Li, J., Liang, X., & Yang, X. (2012). Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Oncology Reports, 28(2), 501–510. https://doi.org/10.3892/or.2012.1827
Li, Z.-Y., Chen, S.-Y., Weng, M.-H., & Yen, G.-C. (2021). Ursolic acid restores sensitivity to gemcitabine through the RAGE/NF-κB/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model. Journal of Food and Drug Analysis, 29(2), 262–274. https://doi.org/10.38212/2224-6614.3346
Liu, P., Ying, Q., Liu, H., Yu, S.-Q., Bu, L.-P., Shao, L., & Li, X.-Y. (2020). Curcumin enhances anti-cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells. Oncology Reports, 44(4), 1393–1402. https://doi.org/10.3892/or.2020.7713
Lee, J. S., Sul, J. Y., Park, J. B., Lee, M. S., Cha, E. Y., & Ko, Y. B. (2019). Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway. International Journal of Molecular Medicine, 43(5), 1969–1978. https://doi.org/10.3892/ijmm.2019.4122
Liu, F., Zhang, Y., Xia, X., Han, J., & Cao, L. (2024). Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation. The journal of obstetrics and gynaecology research, 50(6), 1010–1019. https://doi.org/10.1111/jog.15940
Liao, Q., Feng, X., Li, X., Chen, G., Chen, J., Yang, B., Li, K., & Ai, J. (2020). Lapatinib-induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro. Oncology Reports, 44(3), 1127–1135. https://doi.org/10.3892/or.2020.7660
Lorusso, D., Petrelli, F., Coinu, A., Raspagliesi, F., & Barni, S. (2014). A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecologic Oncology, 133(1), 117–123. https://doi.org/10.1016/j.ygyno.2014.01.042
Li, L. K., Rola, A. S., Kaid, F. A., Ali, A. M., & Alabsi, A. M. (2016). Goniothalamin induces cell cycle arrest and apoptosis in H400 human oral squamous cell carcinoma: A caspase-dependent mitochondrial-mediated pathway with downregulation of NF-κβ. Archives of oral biology, 64, 28–38. https://doi.org/10.1016/j.archoralbio.2015.12.002
Maniruzzaman, M., Bhuiyan, M. R. H., Jaman, M. S., & Haque, M. S. (2025). MicroRNA dynamics, PTEN/PI3K/AKT signaling, and their relationship to breast cancer: prospects for pharmaceuticals and natural product application. Breast cancer research and treatment, 209(3), 467–485. https://doi.org/10.1007/s10549-024-07600-7
Mitra, S., & Dash, R. (2018). Natural products for the management and prevention of breast cancer. Evidence-Based Complementary and Alternative Medicine, 2018, Article 8324696, 1–23. https://doi.org/10.1155/2018/8324696
Mauceri, H. J., Sutton, H. G., Darga, T. E., Kocherginsky, M., Kochanski, J., Weichselbaum, R. R., & Vokes, E. E. (2012). Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer. Oncology Reports, 27(5), 1625–1629. https://doi.org/10.3892/or.2012.1666
Moaddel, R., Rossi, M., Rodriguez, S., Munk, R., Khadeer, M., Abdelmohsen, K., Gorospe, M., & Ferrucci, L. (2022). Identification of gingerenone A as a novel senolytic compound. PloS one, 17(3), e0266135. https://doi.org/10.1371/journal.pone.0266135
Nam, E. J., Lee, M., Yim, G. W., Kim, J. H., Kim, S., Kim, S. W., & Kim, Y. T. (2013). Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. The Oncologist, 18(7), 843–849. https://doi.org/10.1634/theoncologist.2012-0455
Okada, S., Sakata, Y., Matsuno, S., Kurihara, M., Sasaki, Y., Ohashi, Y., & Taguchi, T. (1999). Phase II study of docetaxel in patients with metastatic pancreatic cancer: A Japanese cooperative study. British Journal of Cancer, 80(3–4), 438–443. https://doi.org/10.1038/sj.bjc.6690375
Okonkwo, S. I., Ezugwu , J. A., Oragwu, I. P., Okonkwo, C. K., Okwuego, P. O., Kene-Okonkwo, A. T., Okonkwo , V. S., & Okonkwo , S. C. (2025). Evaluation of Chitosan-Based Nano-Encapsulated Diterpenoids from Andrographis paniculata for Targeted Anti-Inflammatory Therapy: Roles of Analytical Chemistry Medical Imaging, and Biochemical Assessment. American Journal of Chemistry and Pharmacy, 4(1), 48-53. https://doi.org/10.54536/ajcp.v4i1.5356
Pectasides, D., Fountzilas, G., Papaxoinis, G., Pectasides, E., Xiros, N., Sykiotis, C., Koumarianou, A., Psyrri, A., Panayiotides, J., & Economopoulos, T. (2009). Carboplatin and paclitaxel in metastatic or recurrent cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 19(4), 777–781. https://doi.org/10.1111/IGC.0b013e3181a40a8b
Park, J. Y., Choi, P., Kim, H. K., Kang, K. S., & Ham, J. (2016). Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies. Journal of ginseng research, 40(1), 62–67. https://doi.org/10.1016/j.jgr.2015.04.007
Zhang, Y., Huang, Y., & Dou, D. (2024). Anti-prostate cancer mechanism of black ginseng during the “nine steaming and nine sun-drying” process based on HPLC analysis combined with vector space network pharmacology. Discover oncology, 15(1), 12. https://doi.org/10.1007/s12672-024-00862-z
Rao, S. D., & Pagidas, K. (2010). Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer research, 30(7), 2519–2523.
Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y. Y., & Orlowski, R. Z. (2002). Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer research, 62(13), 3868–3875.
Seo, H.-S., Choi, H.-S., Kim, S. R., Choi, Y. K., Woo, S. M., Shin, I., Woo, J.-K., Park, S.-Y., Shin, Y. C., Ko, S.-G., & Kim, S.-G. (2012). Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NF-κB signaling in HER2-overexpressing breast cancer cells. Molecular and Cellular Biochemistry, 366(1–2), 319–334. https://doi.org/10.1007/s11010-012-1310-2
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Jr., Wood, W. C., & Davidson, N. E. (2008). Weekly paclitaxel in the adjuvant treatment of breast cancer. New England Journal of Medicine, 358(16), 1663–1671. https://doi.org/10.1056/NEJMoa0707056
Sui, X., Han, X., Chen, P., Wu, Q., Feng, J., Duan, T., Chen, X., Pan, T., Yan, L., Jin, T., Xiang, Y., Gao, Q., Wen, C., Ma, W., Liu, W., Zhang, R., Chen, B., Zhang, M., Yang, Z., Kong, N., … Ding, X. (2021). Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling Pathway. Frontiers in molecular biosciences, 7, 602282. https://doi.org/10.3389/fmolb.2020.602282
Sun, M., Estrov, Z., Ji, Y., Coombes, K. R., Harris, D. H., & Kurzrock, R. (2008). Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Molecular Cancer Therapeutics, 7(3), 464–473. https://doi.org/10.1158/1535-7163.MCT-07-2272
Santen, R. J., Petroni, G. R., Fisch, M. J., Myers, C. E., Theodorescu, D., & Cohen, R. B. (2001). Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma. Cancer, 92(8), 2095–2101. https://doi.org/10.1002/1097-0142(20011015)92:8<2095::aid-cncr1550>3.0.co;2-y
Sharata, E. E., Attya, M. E., Khalaf, M. M., Rofaeil, R. R., Hemeida, R. A. M., & Abo-Youssef, A. M. (2025). Unraveling chemotherapy-evoked hepatic dysfunction: A deep dive into cyclophosphamide-related liver injury. Naunyn-Schmiedeberg’s Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04583-0
Sobuj, D. R., Bhuiyan, M. R. H., Rashid, T., Arif, S. I., Rana, M. R. R., Maniruzzaman, M., Akter, S., & Jaman, M. S. (2025). Intermittent fasting as a lifestyle strategy for diabetes and heart health in the United States: A systematic review. Clinical Epidemiology & Public Health. https://doi.org/10.25163/health.3110408
Sobuj, D. R., Bhuiyan, M. R. H., Rashid, T., Arif, S. I., Rana, M. R. R., Maniruzzaman, M., Akter, S., & Jaman, M. S. (2025). Breast cancer in the United States: current treatment and diagnosis strategies, risk factors and preventive methods. International Journal Of Community Medicine And Public Health, 12(12), 5839–5843. https://doi.org/10.18203/2394-6040.ijcmph20254069
Tarhini, A., Kotsakis, A., Gooding, W., Shuai, Y., Petro, D., Friedland, D., Belani, C. P., Dacic, S., & Argiris, A. (2010). Phase II study of everolimus (RAD001) in previously treated small cell lung cancer. Clinical Cancer Research, 16(23), 5900–5907. https://doi.org/10.1158/1078-0432.CCR-10-0802
Vrhovac Madunić, I., Madunić, J., Antunović, M., Paradžik, M., Garaj-Vrhovac, V., Breljak, D., Marijanović, I., & Gajski, G. (2018). Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells. Naunyn-Schmiedeberg’s Archives of Pharmacology, 391(5), 537–550. https://doi.org/10.1007/s00210-018-1486-4
van Leeuwen, F. E., Benraadt, J., Coebergh, J. W. W., Kiemeney, L. A. L. M., Gimbrère, C. H. F., Otter, R., Schouten, L. J., Damhuis, R. A. M., & van den Belt-Dusebout, A. W. (1994). Risk of endometrial cancer after tamoxifen treatment of breast cancer. The Lancet, 343(8895), 448–452. https://doi.org/10.1016/S0140-6736(94)92692-1
Ventura, I., Sanchiz, L., Legidos-García, M. E., Murillo-Llorente, M. T., & Pérez-Bermejo, M. (2023). Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer. Cancers, 16(1), 197. https://doi.org/10.3390/cancers16010197
Wang, S., Hu, G., Chen, L., Ma, K., Hu, C., Zhu, H., Xu, N., Zhou, C., Liu, M., & Jin, Q. (2023). Celastrol acts as a new histone deacetylase inhibitor to inhibit colorectal cancer cell growth via regulating macrophage polarity. Cell Biology International, 47(2), 492–501. https://doi.org/10.1002/cbin.11952
Wang, Y. L., Horng, C. T., Hsieh, M. T., Chen, H. C., Huang, Y. S., Yang, J. S., Wang, G. K., Chiang, J. H., Chen, H. H., Lu, C. C., & Chen, F. A. (2019). Autophagy and apoptotic machinery caused by Polygonum cuspidatum extract in cisplatin-resistant human oral cancer CAR cells. Oncology Reports, 41(4), 2549–2557. https://doi.org/10.3892/or.2019.6985
William, W. N., Papadimitrakopoulou, V., Lee, J. J., Mao, L., Martin, J. W., Thomas, G. J., & Lippman, S. M. (2014). Randomized placebo-controlled trial (RCT) of erlotinib for prevention of oral cancer (EPOC). Journal of Clinical Oncology, 32(15_suppl), 6007-6007. https://doi.org/10.1200/jco.2014.32.15_suppl.6007
Wang, Z., Wu, J., Meng, X., Weng, H., Li, Q., Li, L., Ma, Z., Bi, S., Han, Q., Zhao, H., Liu, C., & Meng, D. (2025). A CpG 1018S/QS-21-adjuvanted HBsAg therapeutic vaccine as a novel strategy against HBV. Vaccines, 13(10), 1014. https://doi.org/10.3390/vaccines13101014
Xavier, C. P. R., Lima, C. F., Pedro, D. F. N., Wilson, J. M., Kristiansen, K., & Pereira-Wilson, C. (2013). Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. The Journal of Nutritional Biochemistry, 24(4), 706–712. https://doi.org/10.1016/j.jnutbio.2012.04.004
Xin, L., Li, F., Yu, H., Xiong, Q., Hou, Q., & Meng, Y. (2023). Honokiol alleviates radiation-induced premature ovarian failure via enhancing Nrf2. American journal of reproductive immunology (New York, N.Y. : 1989), 90(4), e13769. https://doi.org/10.1111/aji.13769
Xinqiang, S., Mu, Z., Lei, C., & Mun, L. Y. (2017). Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer. Clinical and translational science, 10(4), 302–307. https://doi.org/10.1111/cts.12470
You, Y., He, Q., Lu, H., Zhou, X., Chen, L., Liu, H., Lu, Z., Liu, D., Liu, Y., Zuo, D., Fu, X., Kwan, H., & Zhao, X. (2020). Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer. Frontiers in pharmacology, 11, 271. https://doi.org/10.3389/fphar.2020.00271
Yen, C. Y., Chiu, C. C., Haung, R. W., Yeh, C. C., Huang, K. J., Chang, K. F., Hseu, Y. C., Chang, F. R., Chang, H. W., & Wu, Y. C. (2012). Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cells through apoptosis, DNA damage and ROS induction. Mutation research, 747(2), 253–258. https://doi.org/10.1016/j.mrgentox.2012.06.003
Yao, R. R., Zhang, Q. B., Ge, M. X., Li, L., Li, J., Zhou, X. L., Wang, Z. X., & Liang, X. H. (2025). The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantation. Discover oncology, 16(1), 553. https://doi.org/10.1007/s12672-025-02299-4
Zhao, H., Tang, S., Tao, Q., Ming, T., Lei, J., Liang, Y., Xu, H., & colleagues. (2023). Ursolic acid suppresses colorectal cancer by down-regulation of Wnt/β-catenin signaling pathway activity. Journal of Agricultural and Food Chemistry, 71(9), 3981–3993. https://doi.org/10.1021/acs.jafc.2c06775
Zhang, Y., Ge, Y., Chen, Y., Li, Q., Chen, J., Dong, Y., & Shi, W. (2012). Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells. Cell Biochemistry and Function, 30(3), 243–248. https://doi.org/10.1002/cbf.1842
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dipongkar Ray Sobuj, Md. Maniruzzaman, Tamanna Rashid, Mst. Tasnova, Rabeya Akter Rupa, Md. Rakib Rased Rana, Md. Rokibul Hasan Bhuiyan, Md. Sadikuj Jaman
This work is licensed under a Creative Commons Attribution 4.0 International License.
